ArticleAnnals of pancreatic cancer2026

Targeting drug efflux in pancreatic cancer: what the PANTAX trial teaches us about resisting resistance.

Nayef Abdel-Razeq et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.